Lecture 7 - Platelets; Development, Morphology and Function Flashcards
Stages of Platelet Production - Megakaryopoiesis
Starts as megakaryoblast
Then promegakaryocyte
Then megakaryocyte
Lastly platelet
Megakaryocyte
Platelet forming
Typical megakaryocyte is seen with platelets budding off the periphery
Granular cytoplasm fragments, resulting in the formation of platelets
Morphology of Platelets
Mature platelets:
Size - 1-4 microns
Shape - discoid
Appearance - palely basophilic with several punctate basophilic granules
Lifespan of platelets in circulation - ~9.5 days
Ultrastructure of Platelets
Platelets contain different types of granules that can be morphologically identified using transmission electron microscopy These granules contained 'preformed' substances Alpha granules - fibrinogen - FV - vWf - PF4 Dense (bodies) granules - ADP - Ca2+ Also - mitochondria - canalicular system - mictrotubules
Biochemistry of Platelet
Platelets are capable of generating substances which influence platelet function
E.g. the Arachidonic acid pathway which produces Thromboxane A2 which promotes aggregation
A key enzyme in this pathway is cyclooxygenase that converts arachidonic acid to prostaglandin G2 and PGH2
Cyclooxygenase is inhibited by a wide range of drugs that will consequentially impair platelet function
Functions of Platelets
Role in 'primary haemostasis' Forms a haemostatic plug Acts to stem blood loss Several stages - adhesion - release reaction - aggregation
Platelet Plug - Adhesion
First stage of plug formation
Injury to blood vessel exposes collagen
Platelets bind to collagen-bound vWf in the sub-endothelium via GP Ib-V-IX
Collagen binding induces platelet activation
Causes changes in
- platelet biochemistry
- platelet shape (discoid to spherical)
Platelet Plug - Release Reaction
Release of granule contents to the surrounding environment
- dense bodies
- alpha granules
Creates a local prothrombotic/procoagulant environment
Activated platelets also have increased production of Thromboxane A2
Platelet Plug - Recruitment and Aggregation
Release of prothrombotic/procoagulant substances promotes recruitment of additional platelets
Further aggregation
- platelets bridged via vWf and fibrinogen
-> formation of primary haemostatic plug
What are the problems with using automated analysis when measuring platelets?
Large platelets may not be distinguished from small RBC
Large platelets/micro aggregates of platelets not recognised by analysers
Disorders of Platelets
Disorders of platelet number: - thrombocytosis (increased) - thrombocytopenia (decreased) Disorders of platelet function: - thrombopathy
Primary vs Secondary Thrombocytosis
Primary
- ~20% of cases
- due to clonal expansion
- ‘haematopoietic neoplasm’ (myeloproliferative disorder)
- a.k.a. essential thrombocythemia (overproduction of every cell)
Secondary
- ~80% of cases
- due to cytokine stimulated production by bone marrow
- many causes
Pathological Mechanisms of Thrombocytopenia
Decreased production - via bone marrow destruction Sequestration - via splenomegaly Increased destruction - antibody mediated destruction - via immune mediated thrombocytopenia
Clinical Consequences of Thrombocytopenia
<100 x 10^9/L - may haemorrhage esp. with trauma, surgery
<20 x 10^9/L - commonly haemorrhage
Bernard-Soulier Syndrome
Autosomal recessive disorder Deficiency platelet surface receptor GP Ib defect (part of GP-Ib-V-IX) Leads to decreased platelet-vWF binding Then leads to ineffective aggregation Giant platelets evident